ReviewBMC health services research2022

The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS.

Hyerim Ha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.